Positive Recommendation by DSMB to Continue Enrollment of Phase 3 SHIELD II Trial of D-PLEX₁₀₀ to 800 PatientsSHIELD II Enrolled more than ...

We are maintaining our $59 per share fair value estimate for Kilroy Realty after incorporating fourth-quarter results. Our estimate of Kilroy’s long-term weighted average cost of capital is 7.1%, and ...

Operator Good morning, and thank you all for attending the CVS Health Q4 2024 earnings conference call. My name is Brika, and I will be your moderator for today's call. [Operator instructions] I would ...

Operator Hello, and welcome to Freshworks fourth quarter and full year 2024 earnings conference call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there ...

Mr. Cooper Group Inc. ( NASDAQ: COOP) Q4 2024 Earnings Conference Call February 12, 2025 10:00 AM ET Ken Posner - Senior Vice President, Strategic Planning & Investor Relations Jay Bray - Chairman & ...

Q2 2025 Earnings Conference Call February 12, 2025 8:00 AM ETCompany ParticipantsClaus Sauter - Chief Executive OfficerOlaf Tröber ...

Tenet Healthcare Corporation (Tenet) (NYSE: THC) today announced its results for the quarter ended December 31, 2024. "2024 was an outstanding year for Tenet characterized ...

U.S. Food and Drug Administration (FDA) recently accepted the Biologics License Application (BLA) for RP1 plus nivolumab in advanced melanoma for priority review with a PDUFA date of July 22, 2025 ...

Ersodetug, a novel, fully human monoclonal antibody for the treatment of hyperinsulinism (HI), receives Breakthrough Therapy Designation and ...

Edwards Lifesciences (NYSE: EW) today reported financial results for the quarter and full-year ended Dec. 31, 2024. Highlights and Outlook Q4 sales grew 9% to ...